Top Markets
Coin of the day
Ibere Pharmaceuticals Ibere Pharmaceuticals

Ibere Pharmaceuticals

IBER
Clasificación en acciones #19088
Ibere Pharmaceuticals currently lacks significant operational activities, with... Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Precio por acción
$10.18
Última sincronización: 2023-03-01
Capitalización bursátil
$175.61M
Cambio (1 día)
-0.29%
Cambio (1 año)
0.00%
País
US
Comercio Ibere Pharmaceuticals (IBER)
Ganancias de Ibere Pharmaceuticals (IBER)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Ibere Pharmaceuticals, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Ibere Pharmaceuticals desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras